Reuters logo
BRIEF-Newron Pharmaceuticals FY net loss shrinks to EUR 15.2 mln
March 2, 2017 / 6:12 AM / 9 months ago

BRIEF-Newron Pharmaceuticals FY net loss shrinks to EUR 15.2 mln

March 2 (Reuters) - Newron Pharmaceuticals Spa:

* Total revenues have substantially increased to 6.7 million euros ($7.06 million) from 2.4 million euros in 2015 in the reporting period

* Says FY cash used in operations has increased to 19.6 million euros (2015: 12.9 million euros)

* FY net loss at 15.2 million euros versus 22.8 million euros year ago Source text for Eikon:

Further company coverage: ($1 = 0.9496 euros) (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below